Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thursday newspaper round-up: Brexit, Pret A Manger, THG

(Sharecast News) - Rishi Sunak is under growing pressure to offer more help to older workers who have fallen out of the workforce due to ill health, as official figures show a sharp increase in the rates of long-term sickness in every region of the UK except London. Highlighting deep regional divisions, figures from the Office for National Statistics show economic inactivity due to long-term sickness has increased most among 50 to 64-year-olds outside the capital since the Covid pandemic. - Guardian More than three-quarters of firms say the government's post-Brexit trade deal with the EU has not helped them to expand their business in the last two years despite promises that it was an "oven-ready" deal. A survey by the British Chambers of Commerce (BCC) has prompted the business lobby group to present the government with five urgent recommendations for enhancing the agreement, which has left many exporters struggling to sell into the EU under the current terms. - Guardian

Pret A Manger is axing almost all of its vegetarian-only stores as the novelty of meat-free branches wears off. The sandwich chain is to shut or rebrand 75pc of its Veggie Pret stores six years after they first launched. - Telegraph

Sir Tom Hunter, the billionaire investor and philanthropist, has reaffirmed his commitment to THG, insisting that Matt Moulding's struggling beauty-to-nutrition retailer has been a "a real success story" (Greig Cameron writes). Hunter, 61, has had a business relationship with Moulding, 50, since 2009 and been a vocal supporter even as THG - formerly The Hut Group - has stumbled. - The Times

Sharan Pasricha, the wealthy entrepreneur behind Gleneagles and the trendy Hoxton hotel chain, has collected an estimated €260 million by selling the underlying assets of the hotels in Amsterdam and Paris. The near €1 million per room paid by Schroders, the buyer of the two properties, is thought to be the biggest per-room price ever paid in Europe for a hotel without suites. - The Times

Share this article

Related Sharecast Articles

Friday newspaper round-up: Anthropic, JLR, Apple
(Sharecast News) - Anthropic ⁠said on Thursday its AI Claude model hacked ⁠systems of ⁠three organizations during testing, days after rival OpenAI ⁠revealed a rogue agent had gone on a days-long ⁠hacking spree at AI firm Hugging ‌Face. Claude gained ‌unauthorized access to the ‌systems during cybersecurity evaluations after a misconfiguration allowed the models to reach the internet from testing environments that ‌were supposed to be isolated, Anthropic said. - Guardian
Thursday newspaper round-up: Carmakers, worklessness, Macfarlanes
(Sharecast News) - Carmakers are delaying final decisions to invest in UK factories until electric car sales rules are relaxed, according to the head of the British car industry's lobby group. The chief executive of the Society of Motor Manufacturers and Traders (SMMT), Mike Hawes, said those with existing UK operations were considering building new models, but had held back so far. - Guardian
Wednesday newspaper round-up: Apple, Netflix, grid operators
(Sharecast News) - Andy Burnham has been warned by a leading thinktank of "very difficult trade-offs in the next autumn budget" if the Iran war keeps oil prices and inflation high. The National Institute of Economic and Social Research (NIESR) said the new prime minister faced a "challenging inheritance" and his plans to revamp public services would meet severe pressure from persistently higher prices. - Guardian
Tuesday newspaper round-up: Johnson & Johnson, Amazon, Ocado
(Sharecast News) - Johnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby ⁠powder and other talc products caused ⁠ovarian cancer, in a landmark deal that could end a contentious, decade-long legal battle. Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, ⁠representing nearly all of the remaining talc claims against the company. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.